DK2648516T3 - Substituerede pyridinon-pyridinylforbindelser - Google Patents
Substituerede pyridinon-pyridinylforbindelser Download PDFInfo
- Publication number
- DK2648516T3 DK2648516T3 DK11847595.3T DK11847595T DK2648516T3 DK 2648516 T3 DK2648516 T3 DK 2648516T3 DK 11847595 T DK11847595 T DK 11847595T DK 2648516 T3 DK2648516 T3 DK 2648516T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyridinon
- substituted
- pyridinyl compounds
- pyridinyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42007410P | 2010-12-06 | 2010-12-06 | |
PCT/US2011/063608 WO2012078684A1 (en) | 2010-12-06 | 2011-12-06 | Substituted pyridinone-pyridinyl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2648516T3 true DK2648516T3 (da) | 2019-01-02 |
Family
ID=46162793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11847595.3T DK2648516T3 (da) | 2010-12-06 | 2011-12-06 | Substituerede pyridinon-pyridinylforbindelser |
Country Status (13)
Country | Link |
---|---|
US (3) | US20120142709A1 (da) |
EP (2) | EP2648516B1 (da) |
JP (1) | JP5848775B2 (da) |
CN (1) | CN103391718A (da) |
CA (1) | CA2819889C (da) |
DK (1) | DK2648516T3 (da) |
ES (2) | ES2873029T3 (da) |
HR (1) | HRP20181788T1 (da) |
HU (1) | HUE040101T2 (da) |
PL (1) | PL2648516T3 (da) |
PT (1) | PT2648516T (da) |
SI (1) | SI2648516T1 (da) |
WO (1) | WO2012078684A1 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3003039B1 (en) * | 2013-06-07 | 2021-02-24 | Aclaris Therapeutics, Inc. | Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds |
CN104860932B (zh) * | 2015-05-13 | 2018-01-12 | 安阳师范学院 | 一种吡唑啉酮类化合物及其应用 |
CN104892499B (zh) * | 2015-06-26 | 2017-07-21 | 江西省科学院应用化学研究所 | 一种2‑吡啶酮类衍生物的合成方法 |
MX2019010642A (es) * | 2017-03-16 | 2019-10-17 | Celgene Car Llc | Inhibidores de cinasa activada por mitogeno 2 (mk2), sintesis de los mismos, e intermediarios de los mismos. |
BR112022001324A2 (pt) * | 2019-07-31 | 2022-03-22 | Aclaris Therapeutics Inc | Composto, composição farmacêutica e método para tratamento de uma doença mediada por p38 map quinase em um indivíduo necessitando do mesmo |
KR20220161390A (ko) * | 2020-03-27 | 2022-12-06 | 어클라리스 쎄라퓨틱스, 인코포레이티드 | 면역 병태의 치료를 위한 mk2 경로 억제제의 경구 조성물 |
US11767309B2 (en) * | 2020-11-23 | 2023-09-26 | Aclaris Therapeutics, Inc. | Methods of synthesizing substituted pyridinone-pyridinyl compounds |
CA3215746A1 (en) * | 2021-03-31 | 2022-10-06 | Xinthera, Inc. | Mk2 inhibitors and uses thereof |
US11685719B2 (en) | 2021-07-09 | 2023-06-27 | Xinthera, Inc. | Pyridinone MK2 inhibitors and uses thereof |
WO2023001282A1 (zh) * | 2021-07-23 | 2023-01-26 | 南京明德新药研发有限公司 | 杂环取代的嘧啶衍生物 |
TW202315625A (zh) * | 2021-08-13 | 2023-04-16 | 大陸商深圳信立泰藥業股份有限公司 | 三聯吡啶二酮化合物或其鹽、包括其藥物組合物及其用途 |
CN116354935A (zh) * | 2021-12-29 | 2023-06-30 | 上海美悦生物科技发展有限公司 | 一种p38 MAPK/MK2通路调节剂及其组合物、制备方法和用途 |
WO2023125707A1 (zh) * | 2021-12-29 | 2023-07-06 | 上海美悦生物科技发展有限公司 | 一种p38 MAPK/MK2通路调节剂及其组合物、制备方法和用途 |
WO2023134765A1 (zh) * | 2022-01-14 | 2023-07-20 | 上海翰森生物医药科技有限公司 | 含五元环类衍生物、其制备方法和应用 |
US20230286950A1 (en) * | 2022-02-04 | 2023-09-14 | Aclaris Therapeutics, Inc. | Methods of synthesizing deuterated substituted pyridinone-pyridinyl compounds |
WO2023217184A2 (zh) * | 2022-05-12 | 2023-11-16 | 上海美悦生物科技发展有限公司 | 取代的吡啶或嘧啶类衍生物及其药物组合物、制备方法和用途 |
WO2024022412A1 (zh) * | 2022-07-28 | 2024-02-01 | 深圳信立泰药业股份有限公司 | 一种式(i)所示的三联吡啶二酮化合物晶型及其制备方法与应用 |
WO2024046327A1 (zh) * | 2022-08-30 | 2024-03-07 | 长春金赛药业有限责任公司 | p38α-MK2抑制剂化合物、药物组合物及其应用 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000017175A1 (en) | 1998-09-18 | 2000-03-30 | Vertex Pharmaceuticals Incorporated | INHIBITORS OF p38 |
EP1178983B1 (en) | 1999-05-21 | 2007-10-24 | Scios Inc. | Indole-type derivatives as inhibitors of p38 kinase |
CA2412172C (en) * | 2000-06-12 | 2012-07-24 | Eisai Co., Ltd. | 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
WO2002042292A2 (en) | 2000-11-20 | 2002-05-30 | Scios Inc. | Indol derivative and their use as inhibitors of p38 kinase |
US7314752B2 (en) | 2001-07-19 | 2008-01-01 | Common Sense, Ltd. | Secretion-monitoring article |
BR0214345A (pt) * | 2001-11-22 | 2004-09-14 | Ono Pharmaceutical Co | Compostos derivados de piperidin-2-ona e composições farmacêuticas contendo estes compostos como ingrediente ativo |
JP4359146B2 (ja) * | 2002-02-13 | 2009-11-04 | エフ.ホフマン−ラ ロシュ アーゲー | 新規なピリジン−およびピリミジン−誘導体 |
PL218749B1 (pl) | 2002-02-14 | 2015-01-30 | Pharmacia Corp | Pochodna pirydynonu oraz jej zastosowanie do wytwarzania leku |
AU2003237121A1 (en) | 2002-04-26 | 2003-11-10 | Vertex Pharmaceuticals Incorporated | Pyrrole derivatives as inhibitors of erk2 and uses thereof |
GB0218630D0 (en) | 2002-08-10 | 2002-09-18 | Tanabe Seiyaku Co | Novel compounds |
EP1549315A4 (en) | 2002-09-11 | 2007-05-23 | Merck & Co Inc | DIHYDROXYPYRIDOPYRAZINE-1,6-DION COMPOUNDS AS HIV INTEGRASE INHIBITORS |
US20070167621A1 (en) | 2003-04-03 | 2007-07-19 | Pharmacia Corporation | Substituted pyrimidinones |
US7183287B2 (en) | 2003-04-03 | 2007-02-27 | Pharmacia Corporation | Substituted pyrimidinones |
NL1026826C2 (nl) | 2003-08-13 | 2007-01-04 | Pharmacia Corp | Gesubstitueerde pyridinonen. |
JP2005255675A (ja) | 2004-02-09 | 2005-09-22 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
CA2555176A1 (en) | 2004-02-11 | 2005-08-25 | Smithkline Beecham Corporation | Hiv integrase inhibitors |
US20080081825A1 (en) * | 2004-04-28 | 2008-04-03 | Hisao Nakai | Nitrogen-Containing Heterocyclic Compounds and Medicinal Use Thereof |
CA2603959A1 (en) | 2005-04-08 | 2006-10-19 | Eisai R & D Management Co., Ltd. | Therapeutic agent for dyskinesia |
WO2007006591A2 (fr) | 2005-07-13 | 2007-01-18 | Bayer Cropscience Sa | Dihalogenation d'hydroxipyridones n,o-disubstituees et leurs utilisations |
WO2007081901A2 (en) | 2006-01-05 | 2007-07-19 | The Scripps Research Institute | Pyrimidinone derivatives as protein kinase inhibitors |
PE20080150A1 (es) | 2006-06-02 | 2008-04-11 | Janssen Pharmaceutica Nv | Derivados de piridinona n-aril y n-heteroaril sustituidos como antagonistas del receptor de la hormona concentradora de melanina (mch) |
WO2008041090A1 (en) * | 2006-10-06 | 2008-04-10 | Pfizer Limited | Malanin concentrating hormone receptor-1 antagonist pyridinones |
US20100056526A1 (en) | 2006-11-24 | 2010-03-04 | Takeda Pharmaceutical Company Limited | Heteromonocyclic compound and use thereof |
RU2009125620A (ru) | 2006-12-07 | 2011-01-20 | Новартис АГ (CH) | Органические соединения |
EP2166857A4 (en) | 2007-06-06 | 2011-03-30 | Xcovery Inc | KINASE INHIBITOR COMPOUNDS |
PL2173737T3 (pl) | 2007-07-17 | 2012-06-29 | Bristol Myers Squibb Co | Sposób modulowania receptora GPR119 sprzężonego z białkiem G i wybrane związki |
CA2729327C (en) | 2008-06-27 | 2016-10-11 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives that modulate the activity of stearoyl-coa desaturase |
US9073925B2 (en) | 2009-07-01 | 2015-07-07 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
US8618299B2 (en) | 2009-07-01 | 2013-12-31 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof |
US8629158B2 (en) | 2009-07-01 | 2014-01-14 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
US8221753B2 (en) * | 2009-09-30 | 2012-07-17 | Tracon Pharmaceuticals, Inc. | Endoglin antibodies |
-
2011
- 2011-12-06 CN CN201180066860XA patent/CN103391718A/zh active Pending
- 2011-12-06 HU HUE11847595A patent/HUE040101T2/hu unknown
- 2011-12-06 PL PL11847595T patent/PL2648516T3/pl unknown
- 2011-12-06 DK DK11847595.3T patent/DK2648516T3/da active
- 2011-12-06 SI SI201131605T patent/SI2648516T1/sl unknown
- 2011-12-06 CA CA2819889A patent/CA2819889C/en active Active
- 2011-12-06 EP EP11847595.3A patent/EP2648516B1/en active Active
- 2011-12-06 JP JP2013543290A patent/JP5848775B2/ja active Active
- 2011-12-06 ES ES18192593T patent/ES2873029T3/es active Active
- 2011-12-06 PT PT11847595T patent/PT2648516T/pt unknown
- 2011-12-06 EP EP18192593.4A patent/EP3469907B1/en active Active
- 2011-12-06 US US13/312,924 patent/US20120142709A1/en not_active Abandoned
- 2011-12-06 WO PCT/US2011/063608 patent/WO2012078684A1/en active Application Filing
- 2011-12-06 ES ES11847595T patent/ES2697607T3/es active Active
-
2014
- 2014-01-07 US US14/149,659 patent/US9365546B2/en active Active
- 2014-01-07 US US14/149,741 patent/US9365547B2/en active Active
-
2018
- 2018-10-30 HR HRP20181788TT patent/HRP20181788T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20181788T1 (hr) | 2018-12-28 |
EP2648516A1 (en) | 2013-10-16 |
CA2819889A1 (en) | 2012-06-14 |
EP3469907B1 (en) | 2021-03-03 |
US20140171449A1 (en) | 2014-06-19 |
US9365547B2 (en) | 2016-06-14 |
JP2013544889A (ja) | 2013-12-19 |
EP2648516A4 (en) | 2014-04-30 |
EP2648516B1 (en) | 2018-09-05 |
PT2648516T (pt) | 2018-11-29 |
ES2873029T3 (es) | 2021-11-03 |
ES2697607T3 (es) | 2019-01-25 |
CA2819889C (en) | 2020-12-15 |
US9365546B2 (en) | 2016-06-14 |
SI2648516T1 (sl) | 2019-01-31 |
CN103391718A (zh) | 2013-11-13 |
PL2648516T3 (pl) | 2019-04-30 |
US20140171450A1 (en) | 2014-06-19 |
WO2012078684A1 (en) | 2012-06-14 |
HUE040101T2 (hu) | 2019-02-28 |
JP5848775B2 (ja) | 2016-01-27 |
US20120142709A1 (en) | 2012-06-07 |
EP3469907A1 (en) | 2019-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013009935C8 (pt) | compostos | |
BR112013003753A2 (pt) | compostos | |
DOP2012000224A (es) | Compuesto heterociclico | |
BR112012028556A2 (pt) | Indóis | |
DE102011100241A8 (de) | Nitridhalbleiterbauteil | |
DK3225404T3 (da) | Fluidpatron | |
CR20130111A (es) | Triazina-oxidiazoles | |
DE10170954T8 (de) | Mikrowellendruckgarer | |
DK2648516T3 (da) | Substituerede pyridinon-pyridinylforbindelser | |
CO6801726A2 (es) | Compuestos | |
DE112011104226A5 (de) | Käfigmutter | |
DK2649070T3 (da) | Triazolpyridinforbindelser | |
DE102011117046A8 (de) | Doppelkupplungswindungsgetriebe | |
DE112011101226A5 (de) | Linearwegmesssystem | |
DE112011102080A5 (de) | Kupplungszentralausrücker | |
DK2442899T3 (da) | Rotorskive | |
DK2539163T3 (da) | Dækventil | |
DE102011002623A8 (de) | Ventilsteuerzeitversteller | |
DE112011102711A5 (de) | Hydrostataktor | |
DK2448659T3 (da) | Rotorskive | |
DK2447426T3 (da) | Vaske-WC | |
BR112012026803A2 (pt) | composto | |
DE102010019119B8 (de) | Cuttermesser | |
BR112013014966A2 (pt) | composto aricíclico contínuo | |
DE102010038420A8 (de) | Reinigungungsvorrichtung |